RecruitingNot ApplicableNCT06491784

EXTRA-Meso (EXercise TheRApy in Mesothelioma) Feasibility

EXercise TheRApy in Mesothelioma - A Feasibility Study


Sponsor

NHS Greater Glasgow and Clyde

Enrollment

40 participants

Start Date

Jan 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn whether running an exercise study in patients with mesothelioma is feasible. The main question(s) it aims to answer are: 1. Is it feasible to recruit patients to a randomised clinical trial of exercise therapy 2. What are the barriers to study recruitment 3. What are the barriers to study retention Participants who decide to take part in the study will be randomly allocated one of two study arms: 1. Standard of care, where the participant will undergo their usual clinical follow-up 2. Exercise therapy, where the participant will receive a personalised 12 week exercise, nutrition and wellbeing programme Participants in both study arms will be asked to complete quality of life questionnaires and a basic fitness assessment at the start and end of the study follow-up period. Participants will be asked if they would be happy to conduct a short interview with a member of the research team, to assess their views on the study. This interview will be audio recorded and the audio recording will be transcribed anonymously to allow researchers to improve future study design.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Diagnosis of mesothelioma, ratified by a mesothelioma multi-disciplinary team (MDT) meeting
  • Performance status 0 - 2
  • Clinical frailty score ≤5
  • Informed written consent

Exclusion Criteria3

  • Performance status ≥3
  • Clinical frailty score ≥6
  • Unlikely to be able to participate in an exercise programme (clinician/physiotherapist judgement)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExercise Therapy

12 week personalised exercise, nutrition and wellbeing programme


Locations(2)

Queen Elizabeth University Hospital

Glasgow, United Kingdom

Wythenshawe Hospital

Manchester, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06491784


Related Trials